Dermalase Now Offers Frisco, Texas the Revolutionary enlighten III – the First 3-Wavelength Picosecond Platform
Frisco – June 28, 2018 – Dermalase (www.dermalase.net) announced today that it has purchased the enlighten III, the latest advancement in picosecond technology multi-color tattoo removal, the treatment of benign epidermal and dermal pigment as well as skin revitalization.
Manufactured by Cutera, Inc., the trusted authority in energy-based medical aesthetic technologies, enlighten III features three proven wavelengths, dual pulse durations specifically chosen to address the widest range of colors, pigments and skin concerns. At Dermalase we invest in the safest and most effective aesthetic technologies for our patients. We are excited to add enlighten III to our practice, the latest innovation in picosecond technology.
With the addition of the 670 nm, Cutera’s newest picosecond wavelength, we can address deeper, denser pigments as well as blue and green tattoos more effectively than ever before. We are really excited to bring these benefits and added treatment applications to Dermalase.
enlighten III offers better clearance of difficult-to-treat tattoos and introduces newtreatment applications to address epidermal and dermal pigmentary concerns and skin revitalization on all skin types. “The innovations in enlighten III allow for superior patient outcomes, and we are thrilled to have practices like Dermalase that have ample experience in laser tattoo removal embrace enlighten.” said Michael Karavitis, Ph.D, Chief Technology Officer at Cutera, Inc.
For more information, contact Dermalase today!